1095 related articles for article (PubMed ID: 30306351)
1. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
2. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
3. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
Rowniak S; Bolt L; Sharifi C
JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
[TBL] [Abstract][Full Text] [Related]
5. Hormone Therapy for Transgender Adults.
Radix A
Urol Clin North Am; 2019 Nov; 46(4):467-473. PubMed ID: 31582021
[TBL] [Abstract][Full Text] [Related]
6. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
7. Reduction in Mental Health Treatment Utilization Among Transgender Individuals After Gender-Affirming Surgeries: A Total Population Study.
Bränström R; Pachankis JE
Am J Psychiatry; 2020 Aug; 177(8):727-734. PubMed ID: 31581798
[TBL] [Abstract][Full Text] [Related]
8. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
[TBL] [Abstract][Full Text] [Related]
9. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
J Sex Med; 2022 Jul; 19(7):1173-1184. PubMed ID: 35418328
[TBL] [Abstract][Full Text] [Related]
10. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
11. Gender minority stress in transgender people: a major role for social network.
Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
[TBL] [Abstract][Full Text] [Related]
12. A Cross-Sectional Multicenter Study of Multidimensional Body Image in Adolescents and Adults with Gender Dysphoria Before and After Transition-Related Medical Interventions.
Becker I; Auer M; Barkmann C; Fuss J; Möller B; Nieder TO; Fahrenkrug S; Hildebrandt T; Richter-Appelt H
Arch Sex Behav; 2018 Nov; 47(8):2335-2347. PubMed ID: 30088234
[TBL] [Abstract][Full Text] [Related]
13. Fertility preservation for transgender adolescents and young adults: a systematic review.
Baram S; Myers SA; Yee S; Librach CL
Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
15. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
Nieder TO; Briken P; Richter-Appelt H
Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
[No Abstract] [Full Text] [Related]
16. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.
Arrington-Sanders R; Connell NT; Coon D; Dowshen N; Goldman AL; Goldstein Z; Grimstad F; Javier NM; Kim E; Murphy M; Poteat T; Radix A; Schwartz A; St Amand C; Streed CG; Tangpricha V; Toribio M; Goldstein RH
Endocr Pract; 2023 Apr; 29(4):272-278. PubMed ID: 36539066
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
18. Assessment and support of children and adolescents with gender dysphoria.
Butler G; De Graaf N; Wren B; Carmichael P
Arch Dis Child; 2018 Jul; 103(7):631-636. PubMed ID: 29650510
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
